At 11 am, Marksans Pharma shares were trading at Rs 113.45, up by 6.44% from its previous closing of Rs 109.40 on the BSE. Marksans Pharma’s wholly owned subsidiary, Time-Cap Laboratories, Inc. has received the Establishment Inspection Report (EIR) from US Food & Drugs Administration (USFDA) for an audit conducted in October 2023. No 483’s …